
GlycoMimetics GLYC
Annual report 2025
added 02-26-2026
GlycoMimetics EV/EBITDA Ratio 2011-2026 | GLYC
Annual EV/EBITDA Ratio GlycoMimetics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.412 | -0.726 | -0.455 | -4.88 | -16 | -2.44 | -3.39 | -7.34 | -0.88 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.412 | -16 | -3.97 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-31.5 | $ 330.79 | 3.74 % | $ 43.3 B | ||
|
BioLineRx Ltd.
BLRX
|
-53.5 | $ 2.34 | 5.72 % | $ 908 M | ||
|
I-Mab
IMAB
|
595 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
-82.4 | - | -9.65 % | $ 45.9 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-12 | $ 3.01 | 0.5 % | $ 257 M | ||
|
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | ||
|
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - | ||
|
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | ||
|
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-0.0369 | - | 10.36 % | $ 9.8 M | ||
|
Aquestive Therapeutics
AQST
|
-7.26 | $ 4.11 | -0.48 % | $ 439 M | ||
|
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-2.37 | $ 8.24 | 2.55 % | $ 226 M | ||
|
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | ||
|
CureVac N.V.
CVAC
|
-7.74 | - | - | $ 867 M | ||
|
AstraZeneca PLC
AZN
|
76.5 | - | - | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
0.185 | $ 31.36 | 0.97 % | $ 2.08 B | ||
|
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.957 | - | 1083.1 % | $ 745 M | ||
|
Axcella Health
AXLA
|
-0.816 | - | -16.42 % | $ 249 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-4.86 | $ 23.46 | -0.72 % | $ 2.98 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M | ||
|
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B | ||
|
BioNTech SE
BNTX
|
4.1 | $ 90.94 | -0.26 % | $ 27.2 B | ||
|
bluebird bio
BLUE
|
-0.805 | - | - | $ 546 M | ||
|
Allakos
ALLK
|
-1.56 | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
0.668 | - | -5.38 % | $ 6.06 M | ||
|
Ardelyx
ARDX
|
0.0336 | $ 6.01 | 1.18 % | $ 1.45 B | ||
|
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | ||
|
CASI Pharmaceuticals
CASI
|
-26.1 | - | - | $ 35.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | ||
|
ChemoCentryx
CCXI
|
-0.721 | - | - | $ 3.74 B | ||
|
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | ||
|
argenx SE
ARGX
|
-39.4 | $ 749.21 | 0.37 % | $ 25 B |